TRxADE HEALTH (MEDS) Competitors $0.94 +0.05 (+5.14%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesSEC FilingsTrendsBuy This Stock MEDS vs. UGRO, GNLN, CTNT, GWAV, JXG, JXJT, WTER, BIMI, CUEN, and AENTWShould you be buying TRxADE HEALTH stock or one of its competitors? The main competitors of TRxADE HEALTH include urban-gro (UGRO), Greenlane (GNLN), Cheetah Net Supply Chain Service (CTNT), Greenwave Technology Solutions (GWAV), Aquaron Acquisition (JXG), JX Luxventure (JXJT), Alkaline Water (WTER), BIMI (BIMI), Cuentas (CUEN), and Alliance Entertainment (AENTW). These companies are all part of the "wholesale" industry. TRxADE HEALTH vs. Its Competitors urban-gro Greenlane Cheetah Net Supply Chain Service Greenwave Technology Solutions Aquaron Acquisition JX Luxventure Alkaline Water BIMI Cuentas Alliance Entertainment urban-gro (NASDAQ:UGRO) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap wholesale companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Which has more risk and volatility, UGRO or MEDS? urban-gro has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.32, indicating that its stock price is 132% more volatile than the S&P 500. Which has higher valuation and earnings, UGRO or MEDS? TRxADE HEALTH has lower revenue, but higher earnings than urban-gro. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratiourban-gro$71.54M0.11-$25.44M-$1.12-0.53TRxADE HEALTH$7.45M0.18-$17.84MN/AN/A Does the media refer more to UGRO or MEDS? In the previous week, urban-gro had 2 more articles in the media than TRxADE HEALTH. MarketBeat recorded 2 mentions for urban-gro and 0 mentions for TRxADE HEALTH. urban-gro's average media sentiment score of 1.45 beat TRxADE HEALTH's score of 0.00 indicating that urban-gro is being referred to more favorably in the media. Company Overall Sentiment urban-gro Positive TRxADE HEALTH Neutral Do insiders and institutionals have more ownership in UGRO or MEDS? 20.6% of urban-gro shares are owned by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are owned by institutional investors. 26.9% of urban-gro shares are owned by insiders. Comparatively, 48.4% of TRxADE HEALTH shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is UGRO or MEDS more profitable? urban-gro has a net margin of 0.00% compared to TRxADE HEALTH's net margin of -149.81%. urban-gro's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets urban-groN/A N/A N/A TRxADE HEALTH -149.81%-196.79%-112.21% Do analysts recommend UGRO or MEDS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score urban-gro 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00TRxADE HEALTH 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Summaryurban-gro beats TRxADE HEALTH on 9 of the 13 factors compared between the two stocks. Get TRxADE HEALTH News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDS vs. The Competition Export to ExcelMetricTRxADE HEALTHDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.33M$2.43M$5.75B$10.26BDividend YieldN/AN/A5.72%4.60%P/E RatioN/AN/A75.2626.44Price / Sales0.180.18456.1288.47Price / CashN/AN/A25.8129.91Price / Book2.102.1013.256.27Net Income-$17.84M-$17.84M$3.29B$270.47M7 Day Performance6.45%2.15%0.68%2.74%1 Month Performance-22.03%-7.34%4.54%5.95%1 Year Performance-87.13%-29.04%73.36%25.97% TRxADE HEALTH Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDSTRxADE HEALTHN/A$0.94+5.1%N/A-87.1%$1.33M$7.45M0.0050UGROurban-gro1.3315 of 5 stars$0.40-2.5%N/A-59.4%$5.25M$71.54M0.00100Positive NewsShort Interest ↓High Trading VolumeGNLNGreenlane0.6066 of 5 stars$3.25-4.4%N/A-99.9%$4.71M$13.27M0.00260Positive NewsGap DownCTNTCheetah Net Supply Chain Service1.6336 of 5 stars$1.67+0.2%N/A-55.7%$4.46M$460K0.0018Positive NewsShort Interest ↓High Trading VolumeGWAVGreenwave Technology Solutions0.2277 of 5 stars$6.26-7.9%N/A-84.9%$3.89M$33.32M0.0090Short Interest ↑JXGAquaron Acquisition0.7918 of 5 stars$1.00+3.0%N/AN/A$2.18M$49.84M0.0057Positive NewsJXJTJX LuxventureN/A$0.97-4.7%N/A-39.5%$588K$38.49M0.0057WTERAlkaline Water0.2734 of 5 stars$0.02-5.9%N/A-84.0%$314K$62.39M-0.4040Gap DownBIMIBIMIN/A$0.00flatN/AN/A$1K$12.63M0.00520CUENCuentas0.0176 of 5 stars$0.00-66.7%N/A-99.9%$1K$1.79M0.005Trending NewsGap DownAENTWAlliance EntertainmentN/A$0.32+23.0%N/A+1,084.5%$0.00$1.07B0.00847Gap Up Related Companies and Tools Related Companies urban-gro Competitors Greenlane Competitors Cheetah Net Supply Chain Service Competitors Greenwave Technology Solutions Competitors Aquaron Acquisition Competitors JX Luxventure Competitors Alkaline Water Competitors BIMI Competitors Cuentas Competitors Alliance Entertainment Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDS) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDS Stock Alerts